Results 111 to 120 of about 88,910 (264)

A COMPRAHENSIVE REVIEW OF PHARMACOLOGICAL AND THERAPEUTICAL ACTIVITIES OF ANTIHYPERTENSIVE DRUG RAMIPRIL

, 2017
M.Hareesh Reddy and Dr.A. Sambasiva Rao
openalex   +2 more sources

Artificial intelligence‐driven anticancer peptide discovery

iMetaOmics, EarlyView.
This review systematically summarized 68 artificial intelligence (AI) models for anticancer peptide (ACP) screening and presented a comprehensive AI‐based framework. The framework consists of six components: data collection and organization, feature extraction, model construction, interpretability analysis, experimental validation, and integration with
Junrui Wu, Shuaiqi Ji, Kashif Iqbal Sahibzada, Mengxue Lou, Feiyu An, Wenqian Li, Jiawei Guo, Taowei Zhang, Xinyi Zhang, Yilin Chou, Henan Zhang, Hao Jin, Teng Ma, Weichi Liu, Begali Alikulov, Natalia Alekseevna Golovneva, Hooi Ling Foo, Issayeva Kuralay, Zhihong Sun, Dongqing Wei, Rina Wu   +20 more
wiley   +1 more source

Determinant Factors Affecting Adherence of Hypertensive Patients to Taking Antihypertensive Drugs

, 2022
A. A. Suryantara, I Gede Putu Darma Suyasa, Ni Putu Kamaryati, Ida Diyu   +3 more
openalex   +1 more source

A “One‐Pot” Metal‐Free Synthesis and Evaluation of Antiproliferative Activity of Diversely Functionalized Pyrrolidine‐2‐Ones

Journal of Heterocyclic Chemistry, EarlyView.
A new “one‐pot” metal‐free stereoselective method for the synthesis of novel diversely functionalized pyrrolidine‐2‐ones from N‐alkyl‐ or N‐arylsulfonamidoacetophenones was developed. The majority of obtained compounds possess low micromolar antiproliferative activities.
Samuel Dick, Matija Bekic, David Meuter, Gary Angles, Victoria Sena, Tatiana Timofeeva, Arturo Lopez Villalobos, Liliya V. Frolova   +7 more
wiley   +1 more source

Endothelial Function Is Impaired in Patients Receiving Antihypertensive Drug Treatment Regardless of Blood Pressure Level [PDF]

, 2017
Tatsuya Maruhashi, Junko Soga, Noritaka Fujimura, Naomi Idei, Shinsuke Mikami, Yumiko Iwamoto, Akimichi Iwamoto, Masato Kajikawa, Takeshi Matsumoto, Nozomu Oda, Shinji Kishimoto, Shogo Matsui, Haruki Hashimoto, Yoshiki Aibara, Farina Mohamad Yusoff, Takayuki Hidaka, Yasuki Kihara, Kazuaki Chayama, Kensuke Noma, Ayumu Nakashima, Chikara Goto, Hirofumi Tomiyama, Bonpei Takase, Takahide Kohro, Toru Suzuki, Tomoko Ishizu, Shinichiro Ueda, Tsutomu Yamazaki, Tomoo Furumoto, Kazuomi Kario, Teruo Inoue, Shinji Koba, Kentaro Watanabe, Yasuhiko Takemoto, Takuzo Hano, Masataka Sata, Yutaka Ishibashi, Koichi Node, Koji Maemura, Yusuke Ohya, Taiji Furukawa, Hiroshi Ito, Hisao Ikeda, Akira Yamashina, Yukihito Higashi   +44 more
openalex   +1 more source

Exploring the roles and impacts of pharmacists embedded in general practice: a scoping review

Journal of Pharmacy Practice and Research, EarlyView.
Abstract Background The role of the general practice pharmacist (GPP) in Australia is not yet clearly defined, and their clinical expertise remains underutilised in general practice settings. This may be attributed to a limited understanding of pharmacists' capabilities, which can hinder optimal GPP utilisation.
Christel Chandra, Brooke Bevis, Nazanin Falconer, Holly Foot   +3 more
wiley   +1 more source

Clinical Study on the Effects of Antihypertensive Drugs

, 1973
Rin Chang, Sung Ho Lee
openalex   +1 more source

Responses of the ambulatory arterial stiffness index and other measures of arterial function to antihypertensive drugs [PDF]

, 2011
Yu Jin, Lutgarde Thijs, Tom Richart, Yan Li, Eamon Dolan, Ji‐Guang Wang, Athanase D. Protogerou, Eoin OʼBrien, Jan A. Staessen, Michel E. Safar   +9 more
openalex   +1 more source

Dynamics of Cardiometabolic Risk Factors Are Linked to the Risk of Hypertension and Diabetes in MASLD

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT This study investigates the impact of cardiometabolic risk factors (CMRF) on the prevalence and incidence of hypertension (HTN) and diabetes mellitus (DM) in individuals with metabolic dysfunction‐associated steatotic liver disease (MASLD) and nonsteatotic liver disease (non‐SLD), using both cross‐sectional and longitudinal data. A total of 32,
Chin‐I Shih, Ming‐Lun Yeh, Yi‐Hung Lin, Ping‐Tsung Shih, Kuan‐Ta Wu, Meng‐Hsuan Hsieh, Jeng‐Fu Yang, Yi‐Yu Chen, Po‐Cheng Liang, Yu‐Ju Wei, Pei‐Chien Tsai, Ya‐Yun Cheng, Ming‐Yen Hsieh, Chih‐Wen Wang, Chung‐Feng Huang, Jee‐Fu Huang, Chia‐Yen Dai, Chi‐Kung Ho, Wan‐Long Chuang, Vincent Wai‐Sun Wong, Wei‐Ting Chang, Ming‐Lung Yu   +21 more
wiley   +1 more source

Impact of Denosumab Adherence on Renal Function and Mortality Rates in Type 2 Diabetes Patients With Osteoporosis

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Type 2 diabetes mellitus (T2DM) is associated with an increased risk of osteoporosis and fractures, and denosumab, a non‐kidney‐excreted antiresorptive medication, represents a viable alternative to bisphosphonates for osteoporosis treatment in patients with T2DM. This study aimed to investigate the association among denosumab adherence, renal
Yu‐Chuan Chang, Jian‐Chih Chen, Sung‐Yen Lin, Kun‐Der Lin, Pei‐Shan Ho, Chung‐Hwan Chen, Yin‐Chih Fu, Tien‐Ching Lee   +7 more
wiley   +1 more source